Serum CA125 level predicts prognosis in patients with multiple brain metastases from non-small cell lung cancer before and after treatment of whole-brain radiotherapy.
Zeng, Yue-Can
Serum CA125 level predicts prognosis in patients with multiple brain metastases from non-small cell lung cancer before and after treatment of whole-brain radiotherapy. [electronic resource] - Medical oncology (Northwood, London, England) Jul 2014 - 48 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1559-131X
10.1007/s12032-014-0048-y doi
Adult
Aged
Brain Neoplasms--mortality
CA-125 Antigen--blood
Carcinoma, Non-Small-Cell Lung--blood
Female
Humans
Lung Neoplasms--blood
Male
Membrane Proteins--blood
Middle Aged
Multivariate Analysis
Prognosis
Survival Rate
Tumor Burden
Serum CA125 level predicts prognosis in patients with multiple brain metastases from non-small cell lung cancer before and after treatment of whole-brain radiotherapy. [electronic resource] - Medical oncology (Northwood, London, England) Jul 2014 - 48 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1559-131X
10.1007/s12032-014-0048-y doi
Adult
Aged
Brain Neoplasms--mortality
CA-125 Antigen--blood
Carcinoma, Non-Small-Cell Lung--blood
Female
Humans
Lung Neoplasms--blood
Male
Membrane Proteins--blood
Middle Aged
Multivariate Analysis
Prognosis
Survival Rate
Tumor Burden